Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01582672
Brief Title: Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

First Submitted : April 19, 2012
First Submitted that Met QC Criteria : April 20, 2012
First Posted : April 23, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : June 13, 2018
Last Update Posted : June 14, 2018